X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (72397) 72397
Newspaper Article (4734) 4734
Newsletter (4626) 4626
Magazine Article (473) 473
Book Chapter (346) 346
Book / eBook (108) 108
Dissertation (88) 88
Publication (72) 72
Conference Proceeding (52) 52
Web Resource (51) 51
Trade Publication Article (44) 44
Book Review (21) 21
Transcript (20) 20
Streaming Video (15) 15
Reference (8) 8
Government Document (7) 7
Paper (4) 4
Report (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49739) 49739
thromboembolism (42270) 42270
female (28139) 28139
male (23791) 23791
venous thromboembolism (19377) 19377
middle aged (19225) 19225
risk factors (16464) 16464
aged (16278) 16278
adult (15510) 15510
thrombosis (15253) 15253
hematology (10969) 10969
anticoagulants (10091) 10091
anticoagulants - therapeutic use (9774) 9774
surgery (9054) 9054
peripheral vascular disease (8939) 8939
prevention (8273) 8273
thromboembolism - prevention & control (8240) 8240
thromboembolism - etiology (7985) 7985
risk (7798) 7798
research (7760) 7760
pulmonary embolism (7312) 7312
deep-vein thrombosis (6380) 6380
cardiac & cardiovascular systems (6230) 6230
aged, 80 and over (6168) 6168
medicine, general & internal (6156) 6156
retrospective studies (6006) 6006
treatment outcome (5940) 5940
patients (5754) 5754
health risk assessment (5667) 5667
stroke (5595) 5595
mortality (5422) 5422
care and treatment (5419) 5419
warfarin (4997) 4997
cancer (4894) 4894
adolescent (4853) 4853
medical research (4555) 4555
analysis (4542) 4542
anticoagulants - administration & dosage (4518) 4518
venous thrombosis (4486) 4486
pulmonary-embolism (4378) 4378
diagnosis (4331) 4331
abridged index medicus (4273) 4273
pregnancy (4240) 4240
anticoagulants - adverse effects (4115) 4115
incidence (4079) 4079
health aspects (4055) 4055
management (4000) 4000
medicine, experimental (3988) 3988
prospective studies (3968) 3968
venous thromboembolism - prevention & control (3959) 3959
risk assessment (3949) 3949
atrial fibrillation (3929) 3929
time factors (3775) 3775
molecular-weight heparin (3749) 3749
risk-factors (3657) 3657
complications (3628) 3628
prophylaxis (3568) 3568
follow-up studies (3540) 3540
therapy (3495) 3495
animals (3334) 3334
drug therapy (3332) 3332
medicine & public health (3297) 3297
heparin (3179) 3179
anticoagulation (3162) 3162
cardiovascular diseases (3147) 3147
thromboembolism - drug therapy (3083) 3083
disease (3056) 3056
venous thromboembolism - etiology (3003) 3003
postoperative complications - prevention & control (2831) 2831
young adult (2814) 2814
deep vein thrombosis (2745) 2745
prognosis (2720) 2720
embolisms (2704) 2704
oncology (2671) 2671
hemorrhage - chemically induced (2615) 2615
thromboembolism - epidemiology (2569) 2569
heparin - therapeutic use (2558) 2558
venous thromboembolism - epidemiology (2505) 2505
cardiology (2493) 2493
administration, oral (2484) 2484
prevalence (2468) 2468
recurrence (2448) 2448
medicine (2420) 2420
studies (2369) 2369
embolism (2365) 2365
clinical trials (2324) 2324
venous thrombosis - etiology (2319) 2319
child (2316) 2316
venous thrombosis - prevention & control (2271) 2271
bleeding (2262) 2262
pharmacology & pharmacy (2252) 2252
coagulation (2250) 2250
thromboprophylaxis (2242) 2242
rivaroxaban (2240) 2240
hospitals (2229) 2229
hypertension (2200) 2200
enoxaparin (2198) 2198
heparin, low-molecular-weight - therapeutic use (2153) 2153
warfarin - therapeutic use (2118) 2118
fibrinolytic agents - therapeutic use (2116) 2116
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Online Resources - Online (38) 38
Scarborough Hospital - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73208) 73208
German (2923) 2923
French (1985) 1985
Spanish (1015) 1015
Russian (993) 993
Japanese (724) 724
Italian (567) 567
Polish (303) 303
Chinese (293) 293
Portuguese (257) 257
Czech (244) 244
Korean (155) 155
Danish (123) 123
Hungarian (113) 113
Turkish (105) 105
Swedish (103) 103
Dutch (96) 96
Norwegian (62) 62
Croatian (51) 51
Bulgarian (48) 48
Romanian (44) 44
Slovak (40) 40
Hebrew (39) 39
Serbian (35) 35
Finnish (27) 27
Ukrainian (17) 17
Slovenian (15) 15
Persian (10) 10
Lithuanian (6) 6
Estonian (3) 3
Icelandic (3) 3
Afrikaans (2) 2
Arabic (1) 1
Bosnian (1) 1
Georgian (1) 1
Indonesian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Vascular Surgery, ISSN 0741-5214, 08/2017, Volume 66, Issue 2, pp. e32 - e33
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 09/2013, Volume 140, Issue suppl_1, pp. A225 - A225
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 8, pp. 709 - 718
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 23, pp. 2167 - 2177
In this clinical trial of hospitalized medically ill patients, extended thromboprophylaxis (30 days) with apixaban had similar efficacy to that of a shorter... 
REPLACEMENT | MEDICINE, GENERAL & INTERNAL | VENOUS THROMBOEMBOLISM | PULMONARY-EMBOLISM | DOUBLE-BLIND | PREVENTION | PLACEBO-CONTROLLED TRIAL | Pulmonary Embolism - prevention & control | Pyrazoles - therapeutic use | Venous Thromboembolism - mortality | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thromboembolism - epidemiology | Pyrazoles - adverse effects | Acute Disease | Double-Blind Method | Drug Administration Schedule | Hemorrhage - epidemiology | Risk Factors | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Treatment Outcome | Hospitalization | Anticoagulants - adverse effects | Heart Failure - drug therapy | Pulmonary Embolism - mortality | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Pyridones - adverse effects | Respiratory Insufficiency - drug therapy | Drugs | Enoxaparin | Dosage and administration | Venous thrombosis | Product/Service Evaluations | Thrombolytic drugs | Comparative analysis | Drug therapy | Heart failure | Fees & charges | Anticoagulants | Compression | Prophylaxis | Congestive heart failure | Thrombosis | Bleeding | Embolism | Compression therapy | Ultrasonic imaging | Hospitals | Safety | Thromboembolism | Health risk assessment | Ultrasound | Respiratory Insufficiency | Hemorrhage | Life Sciences | Venous Thromboembolism | Heart Failure | Pyrazoles | Pyridones | Human health and pathology | Pulmonary Embolism
Journal Article
Journal Article
1972, 1st ed., 194
Book
Contraception, ISSN 0010-7824, 2013, Volume 87, Issue 1, pp. 93 - 100
Journal Article
Journal of thrombosis and haemostasis, ISSN 1538-7933, 2017, Volume 15, Issue 10, pp. 1963 - 1970
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 13, pp. 1211 - 1222
Journal Article